NCT02241681

Medium Chain Triglycerides Plasma Profile and Their Metabolites After Oral Peptamen Intake

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Société des Produits Nestlé (SPN) · Industry
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Medium Chain Triglycerides (MCT) have been used for many years as a good source of lipid to decrease potential for fat malabsorption. However, the pharmacokinetics of MCT and of their metabolites have not been explored in details. This is an exploratory study aiming at determining the plasma level of MCT and their metabolites after oral intake of Peptamen.

Detailed description

20 subjects will be given 250mL of peptamen 1.5 twice, with 4 hours of interval, on a single day. Plasma kinetics of MCTs and their metabolites will be made over 8 hours from baseline

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Peptamen 1.5	Peptamen will be given twice at the dose of 250 mL, with an interval of 4 hours.

Timeline

• Start date: 2014-10-01
• Primary completion: 2014-11-01
• Completion: 2015-01-01
• First posted: 2014-09-16
• Last updated: 2015-03-26

Locations

1 site across 1 country: Switzerland